Episode 330: ASCO 2024 Highlights

By The Uromigos - Last Updated: June 10, 2024

Silke Gillessen joins Tom and Brian, who give their opinion on new data presented at the conference and it’s new ‘Take Home Message’ format.

Post Tags:Uromigos-ASCO
Advertisement

Related Podcasts

Episode 336: Which Patients Are Not Suitable for 1st Line EVP in Bladder Cancer?
Uromigos-Bladder Cancer
Episode 335: Novel Immune Therapies for Renal Cancer
Uromigos-Kidney Cancer
Episode 334: The Uromigos en Español - ASCO 2024 Round-up
Uromigos-Bladder Cancer
Episode 333: The Uromigos Cup - The Netherlands
Uromigos-Bladder Cancer
Episode 332: The Uromigos Cup - Germany's Entry
Uromigos-Bladder Cancer
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2024 Mashup Media, LLC. All rights reserved.

    Terms of Use | Privacy Policy